Lista de obras -

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

artículo científico publicado en 2020

Changes in renal, bone, lipid, and inflammation markers in HIV-1 patients after combination antiretroviral therapy simplification to dolutegravir monotherapy

scientific article published on 20 August 2019

Convalescent Plasma for COVID-19. A randomized clinical trial

scholarly article by Arvind Gharbharan published in 2020

Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis

artículo científico publicado en 2015

Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1

scientific article published on 19 November 2019

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

artículo científico publicado en 2017

Dolutegravir as maintenance monotherapy: first experiences in HIV-1 patients

artículo científico publicado en 2016

Evidence gathered from randomized clinical trials and observational studies on the equivalence of emtricitabine and Lamivudine

artículo científico publicado en 2015

Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency

artículo científico publicado en 2020

How does weight influence tenofovir disoproxil-fumarate induced renal function decline?

artículo científico publicado en 2015

Hypothetical questionnaires may overestimate willingness to participate in HIV cure research: Comparison of a cross-sectional survey to actual willingness to participate in an HIV cure study in the Netherlands

scientific article published on 13 September 2020

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy

scientific article published on 13 December 2019

Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study

artículo científico publicado en 2019

Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort

artículo científico publicado en 2014

Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA

artículo científico publicado en 2020

Interferon-α Auto-Antibodies in Convalescent Plasma Therapy for COVID-19

artículo científico

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

preprint published November 2021

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort

artículo científico publicado en 2014

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

artículo científico publicado en 2017

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.

artículo científico publicado en 2015

Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients

artículo científico publicado en 2013

Proximal tubular dysfunction in a HIV-1 patient with coadministered tenofovir disoproxil-fumarate and ibuprofen.

artículo científico publicado en 2015

Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.

artículo científico publicado en 2015

SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

artículo científico publicado en 2021

Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain

artículo científico publicado en 2015

Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir

artículo científico publicado en 2021

Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DF.

artículo científico publicado en 2015

Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal

artículo científico publicado en 2015

Somatic complaints and social competence predict success in childhood overweight treatment

artículo científico publicado en 2011

Suggested Relationship Between Hemophagocytic Lymphohistiocytosis and Bartonella henselae

artículo científico publicado en 2016

T cell toxicity of HIV latency reversing agents

article

The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients

artículo científico publicado en 2015

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study.

artículo científico publicado en 2014

Towards the next step: LoViRet patients for HIV-1 cure studies

scientific article published on 20 July 2020

Unite forces to validate biomarkers in the quest for lasting HIV remission

artículo científico publicado en 2016

Lista de obras de

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Changes in renal, bone, lipid, and inflammation markers in HIV-1 patients after combination antiretroviral therapy simplification to dolutegravir monotherapy

Convalescent Plasma for COVID-19. A randomized clinical trial

Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis

Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

Dolutegravir as maintenance monotherapy: first experiences in HIV-1 patients

Evidence gathered from randomized clinical trials and observational studies on the equivalence of emtricitabine and Lamivudine

Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency

How does weight influence tenofovir disoproxil-fumarate induced renal function decline?

Hypothetical questionnaires may overestimate willingness to participate in HIV cure research: Comparison of a cross-sectional survey to actual willingness to participate in an HIV cure study in the Netherlands

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy

Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study

Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort

Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA

Interferon-α Auto-Antibodies in Convalescent Plasma Therapy for COVID-19

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.

Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients

Proximal tubular dysfunction in a HIV-1 patient with coadministered tenofovir disoproxil-fumarate and ibuprofen.

Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.

SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain

Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir

Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DF.

Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal

Somatic complaints and social competence predict success in childhood overweight treatment

Suggested Relationship Between Hemophagocytic Lymphohistiocytosis and Bartonella henselae

T cell toxicity of HIV latency reversing agents

The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study.

Towards the next step: LoViRet patients for HIV-1 cure studies

Unite forces to validate biomarkers in the quest for lasting HIV remission